| Structure | Chemical Name | CAS | MF |
|
1,3-Benzodioxol-5-yl[4-(2-chloroethoxy)phenyl]Methanone
|
259149-65-0
|
C16H13ClO4
|
|
5-[1-[4-(2-Chloroethoxy)phenyl]-2-phenyl-1-buten-1-yl]-1,3-benzodioxole
(E/Z Mixture)
|
259149-68-3
|
C25H23ClO3
|
|
Methyl 3-phenyl-1,2,4-oxadiazole-5-carboxylate
|
259150-97-5
|
C10H8N2O3
|
|
Olsalazine sodium EP Impurity C
|
259151-72-9
|
C13H10N2O4
|
|
4-Ethyl-5-furan-2-yl-4H-[1,2,4]triazole-3-thiol
|
259153-94-1
|
C8H9N3OS
|
|
2-(3,4-Dimethoxybenzyl)-3-(N-benzyl-4-piperidine)propionic acid(donepezil intermediate)
|
259170-03-1
|
C24H31NO4
|
|
1-[2,6-Dichloro-4-(trifluoromethyl)phenyl]-1H-pyrrole
|
259175-24-1
|
C11H6Cl2F3N
|
|
Ac-Arg-Ser-Leu-Lys-AMC
|
259176-76-6
|
C33H51N9O8
|
|
1-Piperidineacetonitrile,4-oxo-(9CI)
|
259180-65-9
|
C7H10N2O
|
|
2-Cyanomethyl-morpholine-4-carboxylic acid tert-butyl ester
|
259180-69-3
|
C11H18N2O3
|
|
N-Boc-piperidine-3-ethylamine
|
259180-77-3
|
C12H24N2O2
|
|
tert-butyl 2-(2-aMinoethyl)Morpholine-4-
carboxylate
|
259180-78-4
|
C11H22N2O3
|
|
[1-(2-AMino-ethyl)-piperidin-4-yl]-carbaMic acid tert-butyl ester
|
259180-79-5
|
C12H25N3O2
|
|
Bicyclo[2.2.1]hept-5-ene-2-methanamine, N-ethyl-, (1R,2S,4R)-rel- (9CI)
|
259181-90-3
|
C10H17N
|
|
Bicyclo[2.2.1]hept-5-ene-2-methanamine, N-ethyl-, (1R,2R,4R)-rel- (9CI)
|
259181-93-6
|
C10H17N
|
|
6,7-Isoquinolinediol, 1-[(1S)-1,2-dihydroxyethyl]-1,2,3,4-tetrahydro- (9CI)
|
259183-94-3
|
C11H15NO4
|
|
(2S)-3,3-dimethyl-2-methylamino-N-[(2S)-4-methyl-2-[[(2S)-2-sulfanyl-4 -(3,4,4-trimethyl-2,5-dioxo-imidazolidin-1-yl)butanoyl]amino]pentanoyl ]butanamide
|
259188-38-0
|
C23H41N5O5S
|
|
Oxiranecarboxamide, N-(1,1-dimethylethyl)- (9CI)
|
259194-98-4
|
C7H13NO2
|
|
(S)-N,N''-Bis-Cbz-3,7-diaminoheptanoic acid
|
259195-59-0
|
C23H28N2O6
|
|
Methyl 4-chloro-6-nitro-quinoline-2-carboxylate
|
259196-22-0
|
C11H7ClN2O4
|
|
1-Piperazinecarboxamide, N-(3-chlorophenyl)-4-[4-(trifluoromethyl)-2-pyridinyl]-
|
259196-24-2
|
C17H16ClF3N4O
|
|
10-[(4-Chlorophenyl)thio]anthracene-9-carboxaldehyde
|
259196-25-3
|
C21H13ClOS
|
|
5-[2-Chloro-5-(trifluoromethyl)phenyl]furfural
|
259196-40-2
|
C12H6ClF3O2
|
|
3-(5-(2-Trifluoromethoxyphenyl)2-furyl)propenoic acid
|
259196-57-1
|
C14H9F3O4
|
|
1,3-Cyclopentadiene-1-carbonitrile,4-(dimethylamino)-(9CI)
|
259198-54-4
|
C8H10N2
|
|
Ac-DMQD-CHO
|
259199-63-8
|
C20H31N5O10S
|
|
CP 31398
|
259199-65-0
|
C22H26N4O
|
|
L-Cysteine, L-cysteinylglycyl-L-glutaminyl-L-arginyl-L-α-glutamyl-L-threonyl-L-prolyl-L-α-glutamylglycyl-L-alanyl-L-α-glutamyl-L-alanyl-L-lysyl-L-prolyl-L-tryptophyl-L-tyrosyl-, cyclic (1→17)-disulfide
|
259206-53-6
|
C82H119N23O27S2
|
|
2-Hydroxy-5-methoxyphenylboronic acid
|
259209-16-0
|
C7H9BO4
|
|
3-Methoxy-2-hydroxyphenyl boronic acid
|
259209-17-1
|
C7H9BO4
|
|
4-Fluoro-2-hydroxyphenylboronic acid
|
259209-20-6
|
C6H6BFO3
|
|
2-Hydroxy-5-methylphenylboronic acid
|
259209-21-7
|
C7H9BO3
|
|
2-Hydroxy-3-methylphenyl boronic acid
|
259209-22-8
|
C7H9BO3
|
|
Boronic acid, (2-hydroxy-3,5-dimethylphenyl)- (9CI)
|
259209-23-9
|
C8H11BO3
|
|
Boronic acid, (3-fluoro-2-hydroxyphenyl)- (9CI)
|
259209-24-0
|
C6H6BFO3
|
|
Boronic acid, (2-hydroxy-4-Methylphenyl)- (9CI)
|
259209-25-1
|
C7H9BO3
|
|
Boronic acid, (2-hydroxy-3,4-dimethylphenyl)- (9CI)
|
259209-31-9
|
C8H11BO3
|
|
Boronic acid, B-(5-ethyl-2-hydroxyphenyl)-
|
259209-32-0
|
C8H11BO3
|
|
Boronic acid, [2-hydroxy-5-(1-methylethyl)phenyl]- (9CI)
|
259209-33-1
|
C9H13BO3
|
|
Boronic acid, (4-ethyl-2-hydroxyphenyl)- (9CI)
|
259209-34-2
|
C8H11BO3
|
|
Adenosine, 2-chloro-N-cycloheptyl-
|
259210-40-7
|
C17H24ClN5O4
|
|
trans-4-(tert-Butyldiphenylsilyloxy)-L-proline
|
259212-61-8
|
C21H27NO3Si
|
|
Pyrrolidine, 2-ethoxy-1-(4-methyl-1-oxo-3-pentenyl)- (9CI)
|
259213-88-2
|
C12H21NO2
|
|
Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, hydrochloride (1:1),(1R,2S)-rel-
|
259214-54-5
|
C8H13NO2.ClH
|
|
1-[[(1,1-dimethylethoxy)carbonyl]amino]-2-ethenyl-,(1S,2R)-
|
259214-55-6
|
C11H17NO4
|
|
Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, hydrochloride (1:1), (1R,2S)-
|
259214-56-7
|
C8H13NO2.ClH
|
|
(1R,2S)-Methyl 1-amino-2-vinylcyclopropanecarboxylate HCl
|
259214-58-9
|
C7H11NO2.ClH
|
|
4-Hydroxy-7-methoxy-quinoline-2-carboxylic acid methyl ester
|
259214-73-8
|
C12H11NO4
|
|
Cyclopropanecarboxylic acid, 1-[[(1,1-dimethylethoxy)carbonyl]amino]-2-ethenyl-, ethyl ester, (1R,2S)-
|
259217-95-3
|
C13H21NO4
|
|
N2-[(2,2-Diphenylethoxy)acetyl]-L-arginine, TFA
|
259218-28-5
|
C22H28N4O4
|
|
2,5-Pyrrolidinedione, 3-(cyclohexylhydroxymethyl)- (9CI)
|
259219-02-8
|
C11H17NO3
|
|
Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, (2S)- (9CI)
|
259221-73-3
|
C8H13NO2
|
|
Cyclopropanecarboxylic acid, 1-[[(1,1-dimethylethoxy)carbonyl]amino]-2-ethenyl-, (1S,2S)-
|
259221-77-7
|
C11H17NO4
|
|
Boc-D-Glu(OAll)-OH
|
259221-91-5
|
C13H21NO6
|
|
Acridine-9-carboxylic acid (3-amino-propyl)-amide
|
259221-98-2
|
C17H17N3O
|
|
Acridine-9-carboxylic acid (6-amino-hexyl)-amide
|
259221-99-3
|
C20H23N3O
|
|
(3-[(Acridine-9-carbonyl)-amino]-propyl)-carbamic acid tert-butyl ester
|
259222-01-0
|
C22H25N3O3
|
|
(6-[(Acridine-9-carbonyl)-amino]-hexyl)-carbamic acid tert-butyl ester
|
259222-02-1
|
C25H31N3O3
|
|
4-Bromo-N,N-bis(2-bromoethyl)benzenamine
|
259223-06-8
|
C10H12Br3N
|
|
Cyclopropanecarboxylic acid, cyclopropylidene-, ethyl ester, (1R)- (9CI)
|
259224-22-1
|
C9H12O2
|
|
DL-Leucine-4,5,5,5,6,6,6-d7
|
259225-40-6
|
C6H6D7NO2
|
|
2-BroMo-4-(broMoMethyl)-1-Methylbenzene
|
259231-26-0
|
C8H8Br2
|
|
3-(3-Fluorophenyl)-pentanedioic acid monomethyl ester
|
259232-08-1
|
C12H13FO4
|
|
Acetamide, N-[(1R,2R)-2-(acetyloxy)cyclopentyl]- (9CI)
|
259233-67-5
|
C9H15NO3
|
|
Acetamide, N-[(1S,2S)-2-(acetyloxy)cyclopentyl]- (9CI)
|
259233-68-6
|
C9H15NO3
|
|
cryodesiccant human fibrinogen
|
259242-63-2
|
|
|
1-Bromo-2-(difluoromethoxy)-3-nitro-benzene
|
259243-49-7
|
C7H4BrF2NO3
|
|
1-[2,6-Dichloro-4-(fluoromethyl)phenyl]-3-methyl-1H-pyrazole-5-carboxylic acid ethyl ester
|
259243-71-5
|
C14H11Cl2F3N2O2
|
|
1-[2,6-Dichloro-4-(fluoromethyl)phenyl]-3-methyl-1H-pyrazole-5-carboxylic acid
|
259243-72-6
|
C12H7Cl2F3N2O2
|
|
Methyl 2-[2-(2,2,2-trichloroacetyl)-1H-pyrrol-1-yl]benzoate
|
259243-93-1
|
C14H10Cl3NO3
|
|
4-Pyridinemethanamine, 2-chloro-α,α-dimethyl-
|
259248-41-4
|
C8H11ClN2
|
|
N-Benzyl-N-[2-(trifluoromethoxy)benzylidene]amine
|
259251-79-1
|
C15H12F3NO
|
|
1-[5-[2-(Trifluoromethoxy)phenyl]-2-furyl]ethan-1-one
|
259251-82-6
|
C13H9F3O3
|
|
3-Chloro-3-(2'-fluoro[1,1'-biphenyl]-4-yl)-2-methylacrylaldehyde
|
259252-07-8
|
C16H12ClFO
|
|
2-([[5-(2-Methoxyphenyl)-1,2,4-oxadiazol-3-yl]methyl]thio)aniline
|
259252-11-4
|
C16H15N3O2S
|
|
1,2-dibenzyl 3-tert-butyl piperazine-1,2,3-tricarboxylate
|
259253-67-3
|
C25H30N2O6
|
|
Cyclopropanecarboxylic acid, 1-amino-2-ethyl-, (2S)- (9CI)
|
259254-47-2
|
C6H11NO2
|
|
4-Oxazolecarboxylicacid,4,5-dihydro-4,5-dimethyl-,methylester,(4R,5R)-rel-
|
259254-64-3
|
C7H11NO3
|
|
Carbamic acid, [(1S)-1-(mercaptomethyl)-2-methylpropyl]-, 1,1-dimethylethyl
|
259257-76-6
|
C10H21NO2S
|
|
(1S,2S)-N,N'-Bis(2-acetyl-3-oxo-2-butenylidene)-1,2-dimesitylethylenediaminato cobalt(II)
|
259259-80-8
|
C32H38CoN2O4
|
|
(R)-3-(3-Pyrrolidinyloxy)pyridine
|
259261-88-6
|
C9H12N2O
|
|
tert-butyl 3-(pyridin-3-yloxy)azetidine-1-carboxylate
|
259262-49-2
|
C13H18N2O3
|
|
1-Boc-3-(3-pyridinyloxy)piperidine
|
259262-50-5
|
C15H22N2O3
|
|
Urea, (4,5-dimethyl-4H-pyrazol-3-yl)- (9CI)
|
259269-08-4
|
C6H10N4O
|
|
4H,6H-Benzo[e]pyrrolo[2,1-c][1,4]oxazepine-4,6-dione, 4,6-Dioxo-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepine
|
259269-45-9
|
C12H7NO3
|
|
Methyl 2'-fluoro[1,1'-biphenyl]-4-carboxylate
|
259269-56-2
|
C10H8F3NO2
|
|
Methyl 5-nitro-2-(1-pyrrolidinyl)benzenecarboxylate
|
259269-68-6
|
C12H14N2O4
|
|
2-Amino-3-bromo-5-fluorobenzoic acid
|
259269-84-6
|
C7H5BrFNO2
|
|
2'-Fluoro[1,1'-biphenyl]-4-carbohydrazide
|
259269-90-4
|
C13H11FN2O
|
|
FP-Biotin
|
259270-28-5
|
C27H50FN4O5PS
|
|
4-(4-fluorophenyl)-2-methyl-6-[5-(1-piperidyl)pentoxy]pyrimidine
|
259525-01-4
|
C21H28FN3O
|
|
3-Piperidinol, 1-acetyl-2-ethenyl-, (2R,3S)-rel- (9CI)
|
259526-27-7
|
C9H15NO2
|
|
N-(2-Succinyl) Fluvoxamine
|
259526-43-7
|
C19H25F3N2O6
|
|
1H-Inden-1-one, 2-ethyl-2-fluoro-2,3-dihydro-
|
259532-53-1
|
C11H11FO
|
|
(2-Thienylmethyl)hydrazine hydrochloride
|
259535-14-3
|
C5H9ClN2S
|
|
OB-3
|
259535-56-3
|
C29H50N8O12S
|
|
3-Pyridinecarboxylicacid,2,3-dihydro-6-methyl-2-oxo-(9CI)
|
259537-47-8
|
C7H7NO3
|
|
5-Cyano-6-methyl (1H)indazole
|
259537-71-8
|
C9H7N3
|
|
tert-Butyl (R)-2-(azidomethyl)-1-pyrrolidinecarboxylate
|
259537-91-2
|
C10H18N4O2
|
|
(R)-2-(Aminomethyl)-1-N-Boc-pyyrolidine
|
259537-92-3
|
C10H20N2O2
|